By 48 weeks, significant average weight loss was seen at all maintenance doses: With longer treatment lasting up to 68 weeks, weight loss continued, particularly at higher doses: 12mg: average weight loss of up to 28.7% of body weight This longer-term data shows that weight loss with retatrutide can continue beyond one year, rather than plateauing early, especially at higher maintenance doses
Studies consistently show that bed elevation reduces nighttime reflux episodes by 60% to 70%
Yes, Mounjaro (tirzepatide) can be injected into the upper arm , making it one of three approved injection sites for this medication
Mounjaro, however, contains tirzepatide, which has a dual action, binding to both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, enhancing its effects on weight loss and blood sugar control
The average 8.7% weight loss has been achieved
If erectile dysfunction is severe, distressing, or clearly temporally related to semaglutide initiation without other explanation, discussion of alternative diabetes or weight management therapies may be appropriate